Senior Director, Clinical Operations — Oncology Trials Leader

Revolution Medicines, Inc.; San Francisco (CA); Sur place; USD 244 000 - 305 000; Plein temps

Résumé du poste

Revolution Medicines in Redwood City, CA is seeking a Senior Director of Clinical Operations to lead the design and execution of early-stage clinical studies. You will shape the Clinical Development Plan and oversee trial execution with CROs and sites.

The role requires 12+ years in clinical operations, strong leadership, and extensive experience managing global Phase 1–3 trials under FDA/ICH guidance. Base pay ranges from $244,000 to $305,000 USD and will be set for onsite work.

Qualifications

• BS/MS in a scientific discipline with 12+ years of clinical operations experience.
• Minimum 7 years of project and line management experience.
• Extensive experience leading global phase 1-3 trials within timelines, resources, and budgets.
• Experience in CRO/vendor selection and external resource management.
• Strong knowledge of FDA Regulations, ICH Guidelines and GCPs.

Responsabilités

• Develop and manage the Clinical Development Plan (CDP) including timelines, budgets, and resource needs.
• Oversee execution of clinical trials, including CRO and site selection.
• Deploy Clinical Operations staff and establish clear roles for growth.
• Line management: hiring, performance management and mentorship.
• Collaborate with Clinical Dev, DMPK, Regulatory, QA, Finance, Legal to achieve study goals.

Connaissances

Leadership

Clinical ops

Vendor management

FDA/ICH/GCP knowledge

Data management

Formation

BS/MS in science

Outils

CRO management

Data management systems

Description du poste

Revolution Medicines in Redwood City, CA is seeking a Senior Director of Clinical Operations to lead the design and execution of early-stage clinical studies. You will shape the Clinical Development Plan and oversee trial execution with CROs and sites.

The role requires 12+ years in clinical operations, strong leadership, and extensive experience managing global Phase 1–3 trials under FDA/ICH guidance. Base pay ranges from $244,000 to $305,000 USD and will be set for onsite work.